Acute Kidney Injury Treatment Market to Surpass US$ 3,031.6 Million at a CAGR of 7.2% by 2028 | Quark Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG., B. Braun Melsungen AG

Launch of new products and services is expected to propel growth of the global acute kidney injury treatment market over the forecast period. For example, Baxter International Inc., in October 2018, in association with Mayo Clinic announced to launch Renal Care Center of Excellence in the U.S. to offer guidance about home hemodialysis, chronic kidney disease management, and in-center hemodialysis to those suffering from chronic kidney disease.

Click Here to Get a Sample Copy (Exclusive Offer: UPTO 30% Discount for A Limited Time) @ https://www.coherentmarketinsights.com/insight/request-sample/4691

Moreover, high prevalence of acute kidney injuries is also expected to propel growth of the global acute kidney injury treatment market over the forecast period. For example, around 1% of patients admitted to hospitals have acute kidney injuries at the time of admission in the U.S., according to a study published in Medscape in 2020. Moreover, the estimated incidence rate of acute kidney injuries during hospitalization is 2-5%.

Covid-19 Impact Analysis

Globally, as of 8:32pm CET, 9 February 2022, there have been 399,600,607 confirmed cases of COVID-19, including 5,757,562 deaths, reported to WHO. As of 6 February 2022, a total of 10,095,615,243 vaccine doses have been administered. The pandemic has impacted clinical trials. Medidata Solutions, Inc., in a study published in April 2020, reported that 63% of survey respondents reported stopping recruitment of new patients for ongoing clinical trials and 43% of the respondents stated postponing their studies.

Market Trends

The global acute kidney injury treatment market is witnessing significant investment in R&D. For example, Nephraegis Therapeutics, Inc., in May 2021, announced their launch with a seed investment from Xontogeny, LLC. The company is focused on R&D of NPH-022 to prevent and treat acute kidney injury.

North America is expected to witness significant growth in the global acute kidney injury treatment market, owing to rise in geriatric population. For example, according to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035.

Global Acute Kidney Injury Treatment Market: Competitive Landscape

Major players operating in the global acute kidney injury treatment market include, Asahi Kasei Medical Co., Angion Biomedia Corp., AM-Pharma B.V, Astellas Pharma Inc., Baxter International, Inc., B. Braun Melsungen AG,  Cure Medical, LLC, Fresenius Medical Care,  Medtronic,  Novartis AG.,  Quark Pharmaceuticals, Inc.,   Sentien Biotechnologies, Inc., Teva Pharmaceutical Industries Ltd., Teleflex Incorporated,.

Global Acute Kidney Injury Treatment Market: Key Developments 

Major players operating in the global acute kidney injury treatment market are focused on adopting partnership strategies to expand their product portfolio. For example, Sentien Biotechnologies, Inc., in September 2021, partnered with the Biomedical Advanced Research and Development Authority to assess Sentien Biotechnologies’ ex vivo cell therapy, SBI-101, for the treatment of acute kidney injury associated with sepsis.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/4691

The Study Objectives are:

✔ A comprehensive insight into key players operating in the Acute Kidney Injury Treatment Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Acute Kidney Injury Treatment Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Acute Kidney Injury Treatment Industry Impact

Chapter 2 Global Acute Kidney Injury Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Acute Kidney Injury Treatment (Volume and Value) by Type
2.3 Global Acute Kidney Injury Treatment (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Acute Kidney Injury Treatment Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Acute Kidney Injury Treatment Market Analysis
Chapter 6 East Asia Acute Kidney Injury Treatment Market Analysis
Chapter 7 Europe Acute Kidney Injury Treatment Market Analysis
Chapter 8 South Asia Acute Kidney Injury Treatment Market Analysis
Chapter 9 Southeast Asia Acute Kidney Injury Treatment Market Analysis
Chapter 10 Middle East Acute Kidney Injury Treatment Market Analysis
Chapter 11 Africa Acute Kidney Injury Treatment Market Analysis
Chapter 12 Oceania Acute Kidney Injury Treatment Market Analysis
Chapter 13 South America Acute Kidney Injury Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Acute Kidney Injury Treatment Business
Chapter 15 Global Acute Kidney Injury Treatment Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology